Vial

Vial is a pharmaceutical company based in San Francisco, California, founded in 2020. It focuses on reimagining drug development through a vertically integrated model that combines computational discovery, automated clinical trials, and a proprietary pipeline of biologics and RNA therapeutics. Vial aims to enhance the efficiency of drug development, significantly reducing costs and timelines associated with clinical trials. The company operates its own drug development initiatives through a subsidiary called Battery Bio, utilizing its TrialOS platform for various aspects of clinical trial management. Vial's pipeline includes innovative programs targeting obesity, cardiometabolic diseases, dermatology, respiratory issues, hematology, and inflammatory diseases. It also builds automated labs to improve manufacturing processes in drug discovery. Vial serves biotech companies and has established partnerships to support clinical trials across multiple therapeutic areas.